Actively Recruiting
Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation
Led by Medtronic Vascular · Updated on 2026-04-22
1000
Participants Needed
1
Research Sites
187 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study will assess the long-term effectiveness of the RDN procedure for lowering blood pressure in Medicare patients with uncontrolled hypertension. This research will be conducted using de-identified electronic health records (EHR) and administrative health insurance claims data. Patients are enrolled through the submission of claims or encounter data to CMS.
CONDITIONS
Official Title
Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Enrolled in a Medicare plan
- Diagnosis of uncontrolled hypertension
- On a stable regimen of antihypertensive therapy
You will not qualify if you...
- Prior renal denervation (RDN) procedure
- Diagnosis of secondary hypertension
- Any condition for which renal denervation is contraindicated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
K
Kael Wherry, PhD, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here